Sponsored by Genentech USA, Inc. and Novartis Pharmaceuticals Corporation
Thomas Murphy, MD
This product theater program will be presented by Dr. Thomas Murphy and it will feature a presentation on Targeting Exacerbations in Moderate to Severe Persistent Allergic Asthma. Complimentary dinner will be provided.
- Discuss current challenges in identifying patients with uncontrolled allergic asthma
- Review case studies and clinical data
- Treatment of moderate to severe persistent allergic asthma
- Review efficacy and safety data for a treatment option for appropriate patients with uncontrolled allergic asthma